Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge.
(2011) In PLoS ONE 6(6).- Abstract
 - Induction of broadly neutralizing antibodies, such as the monoclonal antibodies IgGb12, 2F5 and 2G12, is the objective of most antibody-based HIV-1 vaccine undertakings. However, despite the relative conserved nature of epitopes targeted by these antibodies, mechanisms underlying the sensitivity of circulating HIV-1 variants to broadly neutralizing antibodies are not fully understood. Here we have studied sensitivity to broadly neutralizing antibodies of HIV-1 variants that emerge during disease progression in relation to molecular alterations in the viral envelope glycoproteins (Env), using a panel of primary R5 HIV-1 isolates sequentially obtained before and after AIDS onset.
 
    Please use this url to cite or link to this publication:
    https://lup.lub.lu.se/record/2007819
- author
 - organization
 - publishing date
 - 2011
 - type
 - Contribution to journal
 - publication status
 - published
 - subject
 - in
 - PLoS ONE
 - volume
 - 6
 - issue
 - 6
 - article number
 - e20135
 - publisher
 - Public Library of Science (PLoS)
 - external identifiers
 - 
                
- wos:000291734100005
 - pmid:21698221
 - scopus:79959229025
 
 - ISSN
 - 1932-6203
 - DOI
 - 10.1371/journal.pone.0020135
 - language
 - English
 - LU publication?
 - yes
 - id
 - 70cf378e-3896-4b3b-92bd-2a00cd0012af (old id 2007819)
 - alternative location
 - http://www.ncbi.nlm.nih.gov/pubmed/21698221?dopt=Abstract
 - date added to LUP
 - 2016-04-04 09:18:40
 - date last changed
 - 2025-10-14 09:06:46
 
@article{70cf378e-3896-4b3b-92bd-2a00cd0012af,
  abstract     = {{Induction of broadly neutralizing antibodies, such as the monoclonal antibodies IgGb12, 2F5 and 2G12, is the objective of most antibody-based HIV-1 vaccine undertakings. However, despite the relative conserved nature of epitopes targeted by these antibodies, mechanisms underlying the sensitivity of circulating HIV-1 variants to broadly neutralizing antibodies are not fully understood. Here we have studied sensitivity to broadly neutralizing antibodies of HIV-1 variants that emerge during disease progression in relation to molecular alterations in the viral envelope glycoproteins (Env), using a panel of primary R5 HIV-1 isolates sequentially obtained before and after AIDS onset.}},
  author       = {{Borggren, Marie and Repits, Johanna and Sterjovski, Jasminka and Uchtenhagen, Hannes and Churchill, Melissa J and Karlsson, Anders and Albert, Jan and Achour, Adnane and Gorry, Paul R and Fenyö, Eva Maria and Jansson, Marianne}},
  issn         = {{1932-6203}},
  language     = {{eng}},
  number       = {{6}},
  publisher    = {{Public Library of Science (PLoS)}},
  series       = {{PLoS ONE}},
  title        = {{Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge.}},
  url          = {{https://lup.lub.lu.se/search/files/5289400/2172652.pdf}},
  doi          = {{10.1371/journal.pone.0020135}},
  volume       = {{6}},
  year         = {{2011}},
}